---
title: "Metreleptin - Congenital generalized lipodystrophy"
sidebar: mydoc_sidebar
permalink: metreleptincongenitalgeneralizedlipodystrophy.html
toc: false 
---

{% include image.html url="images/metreleptincongenitalgeneralizedlipodystrophy.png" file="metreleptincongenitalgeneralizedlipodystrophy.png" alt="metreleptincongenitalgeneralizedlipodystrophy" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C415771 | Metreleptin | Drug |
| UniProt:P48357 | Leptin receptor | Protein |
| MESH:D020738 | Leptin | ChemicalSubstance |
| UBERON:0001013 | Adipose tissue | GrossAnatomicalStructure |
| MESH:D052497 | Congenital generalized lipodystrophy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Metreleptin | INCREASES ACTIVITY OF | Leptin Receptor |
| Leptin Receptor | POSITIVELY CORRELATED WITH | Leptin |
| Leptin | PRODUCED BY | Adipose Tissue |
| Adipose Tissue | NEGATIVELY CORRELATED WITH | Congenital Generalized Lipodystrophy |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB09046#mechanism-of-action](https://go.drugbank.com/drugs/DB09046#mechanism-of-action){:target="_blank"}